Researchers have made more advancements in multiple sclerosis in the last five years than in the previous 70 years. Knowing ...

Reports of anaphylaxis associated with the use of glatiramer acetate have prompted the Food and Drug Administration (FDA) to add a Boxed Warning to the prescribing information.

Migraine may be a symptom of prodromal multiple sclerosis (MS), as the risk for migraine gradually increased closer to the ...

Patients should stop taking glatiramer acetate and seek immediate medical attention by going to an emergency room or calling ...

The FDA issued a boxed warning for anaphylaxis risk linked to Glatiramer acetate and Glatopa, used in MS treatment.

Since announcing her multiple sclerosis diagnosis in 2018, Selma Blair has been an outspoken advocate for people with MS. The ...

They may be the window to the soul, but researchers have found the eyes also give an insight into the brain that could help ...

Overall, women with MS have a 26% increased risk of mental illness during pregnancy and a 33% increased risk after giving ...

The U.S. Food and Drug Administration on Wednesday warned about the risk of a rare but serious allergic reaction with the use ...

Blood tests are often the first line of testing for evaluating MS symptoms. They can’t confirm a diagnosis of MS, but they can help rule out other conditions or point to a diagnosis. Multiple ...

Relapsing-remitting multiple sclerosis is a type of multiple sclerosis in which you experience relapses of the disease with periods of remission occurring in between. Relapsing-remitting multiple ...